BioSpace News Archive

Drug Development

Eidos Therapeutics Announces Positive Phase 2 Data for AG10 in Symptomatic Patients with Mutant or Wild-Type TTR Amyloid Cardiomyopathy

AG10 Was Well Tolerated in Subjects Administered 400 mg or 800 mg Twice Daily for 28 Days

November 21, 2018
·
8 min read
Business

Alizé Pharma 3 moves forward with building a transatlantic biopharmaceutical company focused on rare endocrine and metabolic diseases

Assembling a diverse portfolio of therapeutic peptides targeting clinical indications with high unmet need

November 21, 2018
·
5 min read
Drug Development

BioMarin Sponsors Off-Broadway Show About Hemophilia

‘Hemophilia: The Musical’ allows teens to share their experiences with the genetic disease.

November 21, 2018
·
2 min read
·
Alex Keown
Drug Development

Synthetic Biologics’ Drug to Prevent C. Diff Infections Gets Phase III Go-Ahead from FDA

The company and the agency discussed the development of SYN-004 (ribaxamase) to prevent antibiotic-mediated Clostridium difficile infection (CDI).

November 21, 2018
·
3 min read
·
Mark Terry
Business

BioArctic Interim Report January – September 2018

BioArctic reports strong BAN2401 Phase 2b results for Alzheimer patients. AbbVie exercises its option to a license for Parkinson’s projects

November 21, 2018
·
8 min read
INTEGRA named ‘2018 Global Laboratory Pipetting Company of the Year’

Frost & Sullivan has presented INTEGRA Biosciences with the ‘2018 Global Laboratory Pipetting Company of the Year’ award, recognizing its products as innovative, revolutionary and able to fulfil the needs of customers.

November 21, 2018
·
2 min read
Artios Pharma Wins 2018 Lifestars EU Private Finance Raise of the Year Award

Artios Pharma Limited is pleased to announce that it has won the 2018 Lifestars “>£30m EU Private Finance Raise of the Year” Award.

November 21, 2018
·
2 min read
Eisai Receives “IR Grand Prix Award”

Eisai Co., Ltd. has announced that it received the “IR Grand Prix Award” at the IR Award 2018 held by the Japan Investor Relations Association (JIRA).

November 21, 2018
·
3 min read
FDA

White House Report Shows Increase in Generics Competition Saved Americans $26 Billion

The report, which was issued by the Council of Economic Advisors, pointed to changes in the approval process at the FDA in the approval process of generic drugs has led to greater competition in the marketplace, which has lowered the costs of the medications.

November 21, 2018
·
2 min read
·
Alex Keown
Job Trends

BioSpace Movers and Shakers: Nov. 26

In a short week leading up to Thanksgiving, several companies made leadership changes as they eye the coming year. We round up who made power moves this past week.

November 21, 2018
·
4 min read
·
Alex Keown